Tobias Speck is an experienced scientist in virology and cancer immunology. He obtained his Bachelors and Masters degree in Molecular Biotechnology from the University of Heidelberg.
In 2014, Tobias joined Guy’s Virotherapy group and obtained his PhD in the development of immunomodulatory oncolytic measles viruses at the German Cancer Research Center in Heidelberg.